NCT07095465Phase 3Enrolling by invitation

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

Study sponsor: ACADIA Pharmaceuticals Inc. · ACAD

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2029-02Estimated

Enrollment · participants126Estimated

Source updated2026-07-24Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2025-12-26 · 1 field changed

Recruitment status

Recorded edit

− Previous value

Not yet recruiting

+ Updated value

Enrolling by invitation

Check registry source